₹ 527.15
5.30 (1.02%)
NSE
Q
Q-Line Biotech
₹ 527.15
NSE
Q-Line Biotech Fundamentals
Company Valuation
Market Cap (₹ Cr.)
1,230
PE Ratio
21.80
PB Ratio
2.49
Dividend Yield
-
ROE
22.63%
ROCE
26.37%
Book Value (₹)
209.24
Face Value (₹)
10.00
Analyse QLINE with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Sep 2025 | May 2026 | Sep 2026 |
|---|---|---|---|
| Promoters | 96.77% | 67.51% | 67.51% |
| Domestic Institutional Investors (DII) | 0.00% | 10.14% | 8.15% |
| Foreign Institutional Investors (FII) | 0.00% | 1.67% | 0.88% |
| Public Investors | 0.00% | 15.97% | 18.43% |
| Government | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
QLINE Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Healthcare Equipment & Supplies
Company Classification
SME
BSE Scrip Code
0
NSE Scrip Name
QLINE
ISIN
INE1G2W01011
Part of Indices

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






